{"public_id":"cl_dddd0ea80c982b7280df43119f4a9a05","status":"active","superseded_by_public_id":null,"corpus_id":12152409,"text":"In a trial of intravenous drug users receiving TB prophylaxis, direct observation showed little difference from no observation in treatment completion (RR 1.00, 95% CI 0.88 to 1.13; one trial, 300 participants).","confidence":0.7,"paper":{"corpus_id":12152409,"title":"Directly observed therapy for treating tuberculosis","url":"https://sah.borca.ai/papers/12152409"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.7,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2d228e5cc25d43b731fa6121e1c15fbe","name":"intravenous drug users","description":"A specific patient population, studied in a USA-based trial, that received direct observation or no observation for TB prophylaxis.","types":["population"],"url":"https://sah.borca.ai/concepts/co_2d228e5cc25d43b731fa6121e1c15fbe"},{"public_id":"co_595ae20c160aceb89d816d707d452a78","name":"TB prophylaxis","description":"Preventive drug therapy given to people at risk of tuberculosis to stop active disease from developing.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_595ae20c160aceb89d816d707d452a78"},{"public_id":"co_b6fb03065c63242d0c280215c0010482","name":"treatment completion","description":"A trial outcome indicating that a patient finished the full prescribed course of TB treatment or prophylaxis.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_b6fb03065c63242d0c280215c0010482"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_dddd0ea80c982b7280df43119f4a9a05"}